Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease
Top Cited Papers
Open Access
- 1 November 2016
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 90 (5), 1115-1122
- https://doi.org/10.1016/j.kint.2016.07.019
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies ConferenceKidney International, 2016
- Anaemia in kidney disease: harnessing hypoxia responses for therapyNature Reviews Nephrology, 2015
- Management of anaemia in chronic kidney disease: summary of updated NICE guidanceBMJ, 2015
- Prevalence of Anemia in Chronic Kidney Disease in the United StatesPLOS ONE, 2014
- The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney diseaseBMC Nephrology, 2013
- Association of Mean Weekly Epoetin Alfa Dose with Mortality Risk in a Retrospective Cohort Study of Medicare Hemodialysis PatientsAmerican Journal of Nephrology, 2011
- Anemia management in chronic kidney diseaseKidney International, 2010
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney DiseaseNew England Journal of Medicine, 2009
- Health-Related Quality of Life and Hemoglobin Levels in Chronic Kidney Disease PatientsClinical Journal of the American Society of Nephrology, 2009
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006